ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 617

$496K Total Retail Price of All Prescriptions

Rank: 104 out of 617

519 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,986 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 562 330 1 1
OMEPRAZOLE 449 283 2 3
FAMOTIDINE 338 189 3 54
SIMVASTATIN 314 279 4 2
AMLODIPINE BESYLATE 289 235 5 6
FUROSEMIDE 285 213 6 4
WARFARIN SODIUM 256 198 7 7
LISINOPRIL 240 188 8 5
GABAPENTIN 238 123 9 16
POTASSIUM CHLORIDE 235 170 10 10
MELOXICAM 204 133 11 24
METOPROLOL SUCCINATE 195 190 12 12
METFORMIN HCL 194 135 13 9
HYDROCODONE-ACETAMINOPHEN 182 145 S3 14 8
METOPROLOL TARTRATE 175 139 15 11
POLYETHYLENE GLYCOL 3350 163 52 16 32
CARBAMAZEPINE 141 12 17 185
TRAMADOL HCL 131 94 18 15
CEPHALEXIN 130 88 19 68
CELEBREX 123 98 20 63
CIPROFLOXACIN HCL 118 81 21 60
HYDROCHLOROTHIAZIDE 106 88 22 13
PREDNISONE 105 70 23 31
ALLOPURINOL 103 93 24 27
ATORVASTATIN CALCIUM 97 78 25 14
CITALOPRAM HBR 96 64 26 18
PHENYTOIN SODIUM EXTENDED 87 23 27 121
KETOCONAZOLE 86 11 28 231
HALOPERIDOL 86 28 28 230
ATENOLOL 86 82 28 17
RISPERIDONE 86 0 28 71
METOCLOPRAMIDE HCL 85 30 32 125
OXYBUTYNIN CHLORIDE 83 27 33 88
OLANZAPINE 79 37 34 139
ALENDRONATE SODIUM 78 67 35 25
PEG 3350-ELECTROLYTE 77 18 36 266
GLYBURIDE 70 32 R 37 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 63 37 29
DONEPEZIL HCL 70 70 37 30
SERTRALINE HCL 66 39 40 20
TAMSULOSIN HCL 65 65 41 26
ESCITALOPRAM OXALATE 65 26 41 65
PROPRANOLOL HCL 64 36 43 109
CLOTRIMAZOLE-BETAMETHASONE 63 36 44 175
SINGULAIR 62 27 45 106
QUETIAPINE FUMARATE 60 0 46 78
ADVAIR DISKUS 60 32 46 38
DIVALPROEX SODIUM ER 60 14 46 181
SYNTHROID 57 37 49 59
LACTULOSE 57 13 49 179
FLUTICASONE PROPIONATE 57 17 49 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 45 52 91
VENLAFAXINE HCL ER 54 0 53 76
CYMBALTA 53 43 54 49
PRIMIDONE 53 34 54 310
DIVALPROEX SODIUM 52 14 56 111
ZOLPIDEM TARTRATE 52 52 56 23
CARVEDILOL 52 40 56 19
LAMOTRIGINE 51 23 59 154
NEXIUM 51 0 59 43
ATENOLOL-CHLORTHALIDONE 51 51 59 142
HYDROXYZINE HCL 50 0 R 62 206
CRESTOR 50 14 62 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.